Provided by Tiger Trade Technology Pte. Ltd.

Pulmonx Corp

1.50
+0.05003.45%
Volume:348.70K
Turnover:516.13K
Market Cap:61.87M
PE:-1.06
High:1.51
Open:1.48
Low:1.45
Close:1.45
52wk High:9.37
52wk Low:1.31
Shares:41.25M
Float Shares:40.27M
Volume Ratio:0.75
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4107
EPS(LYR):-1.4419
ROE:-73.73%
ROA:-23.38%
PB:1.03
PE(LYR):-1.04

Loading ...

Pulmonx Corporation Files Initial Beneficial Ownership Statement for Chief Science & Technology Officer Srikanth Radhakrishnan

Reuters
·
Dec 11, 2025

Director Daniel P. Florin Reports Sale of Pulmonx Corporation Common Shares

Reuters
·
Dec 10, 2025

Pulmonx Grants 1.6 Million Equity Awards to New Executives Under Inducement Plan

Reuters
·
Dec 04, 2025

Pulmonx Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 04, 2025

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Dec 04, 2025

Wells Fargo Sticks to Their Hold Rating for Pulmonx (LUNG)

TIPRANKS
·
Nov 14, 2025

Pulmonx Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 13, 2025

Pulmonx: Buy Rating Affirmed Amid Leadership Return and Promising Growth Prospects

TIPRANKS
·
Nov 13, 2025

Pulmonx Corporation Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 13, 2025

Pulmonx reports Q3 EPS (34c), consensus (42c)

TIPRANKS
·
Nov 13, 2025

Pulmonx cuts FY25 revenue view to $89M-$90M from $90M-$92M

TIPRANKS
·
Nov 13, 2025

Lung treatment firm Pulmonx's Q3 revenue up 5%, net loss narrows marginally

Reuters
·
Nov 13, 2025

Pulmonx Projects 2025 Operating Expenses of Up to $126 Million

Reuters
·
Nov 13, 2025

BRIEF-Pulmonx Q3 EPS USD -0.34

Reuters
·
Nov 13, 2025

Pulmonx Q3 Gross Profit USD 16.052 Million

THOMSON REUTERS
·
Nov 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025

Pulmonx Corporation Files Initial Statement of Beneficial Ownership for COO and CFO Derrick Sung

Reuters
·
Nov 11, 2025

Pulmonx Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 28, 2025

Canaccord Genuity Remains a Buy on Pulmonx (LUNG)

TIPRANKS
·
Oct 28, 2025

Pulmonx (LUNG) Gets a Hold from Piper Sandler

TIPRANKS
·
Oct 28, 2025